Cargando…
Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice
Diabetes mellitus (DM) is one of the major causes of death in the world. There are two types of DM—type 1 DM and type 2 DM. Type 1 DM can only be treated by insulin injection whereas type 2 DM is commonly treated using anti-hyperglycemic agents. Despite its effectiveness in controlling blood glucose...
Autores principales: | Faizah, Zakiyatul, Amanda, Bella, Ashari, Faisal Yusuf, Triastuti, Efta, Oxtoby, Rebecca, Rahaju, Anny Setijo, Aziz, M. Aminudin, Lusida, Maria Inge, Oceandy, Delvac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582334/ https://www.ncbi.nlm.nih.gov/pubmed/32987643 http://dx.doi.org/10.3390/molecules25194381 |
Ejemplares similares
-
Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload
por: Triastuti, Efta, et al.
Publicado: (2019) -
The Cross-Talk Between the TNF-α and RASSF-Hippo Signalling Pathways
por: Oceandy, Delvac, et al.
Publicado: (2019) -
MST1/2 inhibitor XMU‐MP‐1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system
por: Zhou, Xiaoliang, et al.
Publicado: (2022) -
Mst1/2 Kinases Inhibitor, XMU-MP-1, Attenuates Angiotensin II-Induced Ascending Aortic Expansion in Hypercholesterolemic Mice
por: Okuyama, Michihiro, et al.
Publicado: (2021) -
Stem cell therapy and diabetic erectile dysfunction: A critical review
por: Pakpahan, Cennikon, et al.
Publicado: (2021)